{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T22:39:40Z","timestamp":1785364780804,"version":"3.55.0"},"reference-count":178,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.cld.2019.06.003","type":"journal-article","created":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T07:53:37Z","timestamp":1565337217000},"page":"683-711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Pulmonary Complications of Portal Hypertension"],"prefix":"10.1016","volume":"23","author":[{"given":"Rodrigo","family":"Cartin-Ceba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Krowka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cld.2019.06.003_bib1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccm.2012.11.006","article-title":"The light criteria: the beginning and why they are useful 40 years later","volume":"34","author":"Light","year":"2013","journal-title":"Clin Chest Med"},{"issue":"4","key":"10.1016\/j.cld.2019.06.003_bib2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00063198-200307000-00003","article-title":"Hepatic hydrothorax","volume":"9","author":"Kinasewitz","year":"2003","journal-title":"Curr Opin Pulm Med"},{"issue":"3","key":"10.1016\/j.cld.2019.06.003_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/MD.0000000000000025","article-title":"Hepatic hydrothorax: clinical features, management, and outcomes in 77 patients and review of the literature","volume":"93","author":"Badillo","year":"2014","journal-title":"Medicine (Baltimore)"},{"issue":"31","key":"10.1016\/j.cld.2019.06.003_bib4","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.4254\/wjh.v9.i31.1197","article-title":"Hepatic hydrothorax: an update and review of the literature","volume":"9","author":"Garbuzenko","year":"2017","journal-title":"World J Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2019.06.003_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0032-1301729","article-title":"Hepatic hydrothorax","volume":"33","author":"Krok","year":"2012","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.cld.2019.06.003_bib6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000346996","article-title":"Evidence-based review of the management of hepatic hydrothorax","volume":"86","author":"Singh","year":"2013","journal-title":"Respiration"},{"issue":"3","key":"10.1016\/j.cld.2019.06.003_bib7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-2007-1007200","article-title":"Hepatic hydrothorax","volume":"17","author":"Strauss","year":"1997","journal-title":"Semin Liver Dis"},{"issue":"6","key":"10.1016\/j.cld.2019.06.003_bib8","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/00004836-198812000-00019","article-title":"Diaphragmatic defect as a cause of massive hydrothorax in cirrhosis of liver","volume":"10","author":"Chen","year":"1988","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2019.06.003_bib9","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0002-9343(99)00217-X","article-title":"Hepatic hydrothorax: pathogenesis, diagnosis, and management","volume":"107","author":"Lazaridis","year":"1999","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.cld.2019.06.003_bib10","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/hep.28634","article-title":"Diagnosis of isolated hepatic hydrothorax using peritoneal scintigraphy","volume":"64","author":"Hewett","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2019.06.003_bib11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/hep.1840110306","article-title":"Spontaneous bacterial empyema in cirrhotic patients: analysis of eleven cases","volume":"11","author":"Xiol","year":"1990","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2019.06.003_bib12","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/hep.510230410","article-title":"Spontaneous bacterial empyema in cirrhotic patients: a prospective study","volume":"23","author":"Xiol","year":"1996","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2019.06.003_bib13","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1478-3231.2010.02447.x","article-title":"Outcome predictors of cirrhotic patients with spontaneous bacterial empyema","volume":"31","author":"Chen","year":"2011","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.cld.2019.06.003_bib14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1665-2681(19)31831-9","article-title":"Hepatic hydrothorax: current concepts of pathophysiology and treatment options","volume":"7","author":"Kiafar","year":"2008","journal-title":"Ann Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2019.06.003_bib15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.7326\/0003-4819-64-2-341","article-title":"Pathogenesis and treatment of hydrothorax complicating cirrhosis with ascites","volume":"64","author":"Lieberman","year":"1966","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.cld.2019.06.003_bib16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.cld.2014.01.005","article-title":"Hepatic hydrothorax","volume":"18","author":"Norvell","year":"2014","journal-title":"Clin Liver Dis"},{"issue":"1","key":"10.1016\/j.cld.2019.06.003_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00004836-200301000-00020","article-title":"Low complement levels and opsonic activity in hepatic hydrothorax: its relationship with spontaneous bacterial empyema","volume":"36","author":"Sese","year":"2003","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2019.06.003_bib18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/MJT.0b013e318228319e","article-title":"Hepatic hydrothorax","volume":"21","author":"Baikati","year":"2014","journal-title":"Am J Ther"},{"issue":"3","key":"10.1016\/j.cld.2019.06.003_bib19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2036.2004.02081.x","article-title":"Review article: hepatic hydrothorax","volume":"20","author":"Cardenas","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.cld.2019.06.003_bib20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/ajg.2009.634","article-title":"Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis","volume":"105","author":"Dhanasekaran","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2019.06.003_bib21","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/hep.510250611","article-title":"The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt","volume":"25","author":"Gordon","year":"1997","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2019.06.003_bib22","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/lt.500040506","article-title":"Transjugular intrahepatic portosystemic shunts and liver transplantation in patients with refractory hepatic hydrothorax","volume":"4","author":"Jeffries","year":"1998","journal-title":"Liver Transpl Surg"},{"issue":"4","key":"10.1016\/j.cld.2019.06.003_bib23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1051-0443(07)61741-2","article-title":"Safety and efficacy of transjugular intrahepatic portosystemic shunt creation for the treatment of hepatic hydrothorax","volume":"13","author":"Spencer","year":"2002","journal-title":"J\u00a0Vasc Interv Radiol"},{"issue":"9","key":"10.1016\/j.cld.2019.06.003_bib24","first-page":"1520","article-title":"Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax","volume":"89","author":"Strauss","year":"1994","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2019.06.003_bib25","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1378\/chest.126.1.142","article-title":"Outcome analysis of cirrhotic patients undergoing chest tube placement","volume":"126","author":"Liu","year":"2004","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.cld.2019.06.003_bib26","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s12072-009-9136-z","article-title":"Outcomes of patients with chest tube insertion for hepatic hydrothorax","volume":"3","author":"Orman","year":"2009","journal-title":"Hepatol Int"},{"issue":"7","key":"10.1016\/j.cld.2019.06.003_bib27","first-page":"566","article-title":"Hepatic hydrothorax is a relative contraindication to chest tube insertion","volume":"81","author":"Runyon","year":"1986","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2019.06.003_bib28","doi-asserted-by":"crossref","first-page":"5872068","DOI":"10.1155\/2017\/5872068","article-title":"The outcome of thoracentesis versus chest tube placement for hepatic hydrothorax in patients with cirrhosis: a nationwide analysis of the national inpatient sample","volume":"2017","author":"Ridha","year":"2017","journal-title":"Gastroenterol Res Pract"},{"issue":"3","key":"10.1016\/j.cld.2019.06.003_bib29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/1479972311407216","article-title":"The use of the PleurX catheter in the management of non-malignant pleural effusions","volume":"8","author":"Chalhoub","year":"2011","journal-title":"Chron Respir Dis"},{"issue":"6","key":"10.1016\/j.cld.2019.06.003_bib30","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1513\/AnnalsATS.201510-688BC","article-title":"Indwelling tunneled pleural catheters for the management of hepatic hydrothorax. A pilot study","volume":"13","author":"Chen","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.cld.2019.06.003_bib31","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.chest.2016.10.052","article-title":"Management of benign pleural effusions using indwelling pleural catheters: a systematic review and meta-analysis","volume":"151","author":"Patil","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.cld.2019.06.003_bib32","doi-asserted-by":"crossref","first-page":"4013052","DOI":"10.1155\/2016\/4013052","article-title":"Pigtail catheter: a less invasive option for pleural drainage in Egyptian patients with recurrent hepatic hydrothorax","volume":"2016","author":"Sharaf-Eldin","year":"2016","journal-title":"Gastroenterol Res Pract"},{"issue":"3","key":"10.1016\/j.cld.2019.06.003_bib33","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.chest.2018.08.1034","article-title":"Indwelling tunneled pleural catheters for refractory hepatic hydrothorax in patients with cirrhosis: a multicenter study","volume":"155","author":"Shojaee","year":"2019","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.cld.2019.06.003_bib34","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1007\/s10620-016-4260-9","article-title":"Effectiveness and safety of pleurodesis for hepatic hydrothorax: a systematic review and meta-analysis","volume":"61","author":"Hou","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.cld.2019.06.003_bib35","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.athoracsur.2015.11.023","article-title":"Thoracoscopic mesh repair of diaphragmatic defects in hepatic hydrothorax: a 10-year experience","volume":"101","author":"Huang","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cld.2019.06.003_bib36","doi-asserted-by":"crossref","DOI":"10.1053\/j.semtcvs.2019.02.003","article-title":"Predictors of outcomes after thoracic surgery in orthotopic liver transplant recipients with pleural disease","author":"Shirali","year":"2019","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"6","key":"10.1016\/j.cld.2019.06.003_bib37","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1432-2277.2005.00116.x","article-title":"Liver transplantation in patients with hepatic hydrothorax","volume":"18","author":"Xiol","year":"2005","journal-title":"Transpl Int"},{"issue":"1","key":"10.1016\/j.cld.2019.06.003_bib38","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.cld.2019.06.003_bib39","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/TP.0000000000001229","article-title":"International liver transplant society practice guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension","volume":"100","author":"Krowka","year":"2016","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.cld.2019.06.003_bib40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0272-5231(05)70297-5","article-title":"Hepatopulmonary syndrome. A pulmonary vascular complication of liver disease","volume":"17","author":"Castro","year":"1996","journal-title":"Clin Chest Med"},{"issue":"5","key":"10.1016\/j.cld.2019.06.003_bib41","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1183\/09031936.04.00010904","article-title":"Pulmonary-hepatic vascular disorders (PHD)","volume":"24","author":"Rodriguez-Roisin","year":"2004","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.cld.2019.06.003_bib42","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1055\/s-2006-947294","article-title":"Evolving dilemmas and management of portopulmonary hypertension","volume":"26","author":"Krowka","year":"2006","journal-title":"Semin Liver Dis"},{"issue":"6","key":"10.1016\/j.cld.2019.06.003_bib43","doi-asserted-by":"crossref","first-page":"625","DOI":"10.4065\/75.6.625","article-title":"Pulmonary hypertension: diagnostics and therapeutics","volume":"75","author":"Krowka","year":"2000","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.cld.2019.06.003_bib44","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1378\/chest.11-0160","article-title":"Portopulmonary hypertension: a report from the US-based REVEAL registry","volume":"141","author":"Krowka","year":"2012","journal-title":"Chest"},{"issue":"22","key":"10.1016\/j.cld.2019.06.003_bib45","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1056\/NEJMra0707185","article-title":"Hepatopulmonary syndrome--a liver-induced lung vascular disorder","volume":"358","author":"Rodriguez-Roisin","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.cld.2019.06.003_bib46","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-0032-1301731","article-title":"Portopulmonary hypertension","volume":"33","author":"Krowka","year":"2012","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.cld.2019.06.003_bib47","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/hep.22275","article-title":"Clinical risk factors for portopulmonary hypertension","volume":"48","author":"Kawut","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2019.06.003_bib48","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0016-5085(91)90225-A","article-title":"Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics","volume":"100","author":"Hadengue","year":"1991","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2019.06.003_bib49","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1164\/arrd.1983.127.4.437","article-title":"Primary pulmonary hypertension and cirrhosis: are they related?","volume":"127","author":"McDonnell","year":"1983","journal-title":"Am Rev Respir Dis"},{"issue":"9","key":"10.1016\/j.cld.2019.06.003_bib50","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France: results from a national registry","volume":"173","author":"Humbert","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.cld.2019.06.003_bib51","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1053\/jhep.2003.50060","article-title":"Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study","volume":"37","author":"Colle","year":"2003","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2019.06.003_bib52","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/lt.500030503","article-title":"Severe pulmonary hypertension in liver transplant candidates","volume":"3","author":"Ramsay","year":"1997","journal-title":"Liver Transpl Surg"},{"issue":"9","key":"10.1016\/j.cld.2019.06.003_bib53","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1164\/rccm.200809-1472OC","article-title":"Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease","volume":"179","author":"Roberts","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.cld.2019.06.003_bib54","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0735-1097(87)80123-7","article-title":"Coexistent pulmonary and portal hypertension: morphologic and clinical features","volume":"10","author":"Edwards","year":"1987","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.cld.2019.06.003_bib55","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/2045-8932.78095","article-title":"Progenitor cells in pulmonary vascular remodeling","volume":"1","author":"Yeager","year":"2011","journal-title":"Pulm Circ"},{"issue":"8","key":"10.1016\/j.cld.2019.06.003_bib56","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/ATVBAHA.109.191221","article-title":"Estrogen receptors and endothelium","volume":"30","author":"Arnal","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.cld.2019.06.003_bib57","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1164\/ajrccm.159.6.9804054","article-title":"Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension","volume":"159","author":"Tuder","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.cld.2019.06.003_bib58","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1053\/jlts.2000.9735","article-title":"Hepatic localization of endothelin-1 in patients with idiopathic portal hypertension and cirrhosis of the liver","volume":"6","author":"Kamath","year":"2000","journal-title":"Liver Transpl"},{"issue":"9","key":"10.1016\/j.cld.2019.06.003_bib59","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/gut.52.9.1355","article-title":"Portopulmonary hypertension in decompensated cirrhosis with refractory ascites","volume":"52","author":"Benjaminov","year":"2003","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.cld.2019.06.003_bib60","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1177\/0003319710369101","article-title":"Plasma cytokines and portopulmonary hypertension in patients with cirrhosis waiting for orthotopic liver transplantation","volume":"61","author":"Pellicelli","year":"2010","journal-title":"Angiology"},{"issue":"4","key":"10.1016\/j.cld.2019.06.003_bib61","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1053\/jlts.2000.7573","article-title":"Accuracy of Doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates","volume":"6","author":"Kim","year":"2000","journal-title":"Liver Transpl"},{"issue":"8","key":"10.1016\/j.cld.2019.06.003_bib62","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/00007890-199604270-00011","article-title":"Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation","volume":"61","author":"Donovan","year":"1996","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.cld.2019.06.003_bib63","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1053\/jlts.2002.35554","article-title":"Role of echocardiography in detecting portopulmonary hypertension in liver transplant candidates","volume":"8","author":"Cotton","year":"2002","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.cld.2019.06.003_bib64","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/hep.21431","article-title":"Portopulmonary hypertension: results from a 10-year screening algorithm","volume":"44","author":"Krowka","year":"2006","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2019.06.003_bib65","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/lt.23649","article-title":"Echocardiography for the detection of portopulmonary hypertension in liver transplant candidates: an analysis of cutoff values","volume":"19","author":"Raevens","year":"2013","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2019.06.003_bib66","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"suppl 62","key":"10.1016\/j.cld.2019.06.003_bib67","first-page":"OA267","article-title":"Late Breaking Abstract - efficacy and safety of macitentan in portopulmonary hypertension: the PORTICO trial","volume":"52","author":"Sitbon","year":"2018","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.cld.2019.06.003_bib68","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1600-6143.2006.01701.x","article-title":"The impact of treatment of portopulmonary hypertension on survival following liver transplantation","volume":"7","author":"Ashfaq","year":"2007","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.cld.2019.06.003_bib69","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1378\/chest.10-0574","article-title":"Safety and efficacy of ambrisentan for the treatment of portopulmonary hypertension","volume":"139","author":"Cartin-Ceba","year":"2011","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.cld.2019.06.003_bib70","first-page":"77","article-title":"Hepatotoxicity by bosentan in a patient with portopulmonary hypertension: a case-report and review of the literature","volume":"20","author":"Eriksson","year":"2011","journal-title":"J\u00a0Gastrointest Liver Dis"},{"issue":"6","key":"10.1016\/j.cld.2019.06.003_bib71","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/lt.21174","article-title":"Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol","volume":"13","author":"Fix","year":"2007","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.cld.2019.06.003_bib72","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/lt.21533","article-title":"Sildenafil therapy is associated with improved hemodynamics in liver transplantation candidates with pulmonary arterial hypertension","volume":"15","author":"Gough","year":"2009","journal-title":"Liver Transpl"},{"issue":"9","key":"10.1016\/j.cld.2019.06.003_bib73","first-page":"1258","article-title":"Ambrisentan improves exercise capacity and symptoms in patients with portopulmonary hypertension","volume":"49","author":"Halank","year":"2011","journal-title":"Z\u00a0Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2019.06.003_bib74","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/lt.21479","article-title":"Sildenafil monotherapy in portopulmonary hypertension can facilitate liver transplantation","volume":"15","author":"Hemnes","year":"2009","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.cld.2019.06.003_bib75","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1183\/09031936.00094409","article-title":"Liver toxicity: the Achilles' heel of endothelin receptor antagonist therapy?","volume":"34","author":"Hoeper","year":"2009","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.cld.2019.06.003_bib76","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1183\/09031936.00032407","article-title":"Experience with inhaled iloprost and bosentan in portopulmonary hypertension","volume":"30","author":"Hoeper","year":"2007","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.cld.2019.06.003_bib77","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/lt.23407","article-title":"Treatment with sildenafil and treprostinil allows successful liver transplantation of patients with moderate to severe portopulmonary hypertension","volume":"18","author":"Hollatz","year":"2012","journal-title":"Liver Transpl"},{"issue":"7\u20138","key":"10.1016\/j.cld.2019.06.003_bib78","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00508-011-1540-4","article-title":"Successful treatment of portopulmonary hypertension with the selective endothelin receptor antagonist Sitaxentan","volume":"123","author":"Kahler","year":"2011","journal-title":"Wien Klin Wochenschr"},{"issue":"5","key":"10.1016\/j.cld.2019.06.003_bib79","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/lt.500050515","article-title":"Inhaled nitric oxide reduces pulmonary artery pressures in portopulmonary hypertension","volume":"5","author":"Findlay","year":"1999","journal-title":"Liver Transpl Surg"},{"issue":"4","key":"10.1016\/j.cld.2019.06.003_bib80","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/00007890-199702270-00020","article-title":"Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension","volume":"63","author":"Kuo","year":"1997","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.cld.2019.06.003_bib81","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/lt.21997","article-title":"Acute and long-term effects of inhaled iloprost in portopulmonary hypertension","volume":"16","author":"Melgosa","year":"2010","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.cld.2019.06.003_bib82","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1183\/09031936.06.00030206","article-title":"Sildenafil treatment for portopulmonary hypertension","volume":"28","author":"Reichenberger","year":"2006","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.cld.2019.06.003_bib83","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1432-2277.2008.00830.x","article-title":"Initial experience using continuous intravenous treprostinil to manage pulmonary arterial hypertension in patients with end-stage liver disease","volume":"22","author":"Sakai","year":"2009","journal-title":"Transpl Int"},{"issue":"9","key":"10.1016\/j.cld.2019.06.003_bib84","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1111\/j.1600-6143.2006.01432.x","article-title":"Successful liver transplantation following medical management of portopulmonary hypertension: a single-center series","volume":"6","author":"Sussman","year":"2006","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.cld.2019.06.003_bib85","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/MEG.0b013e32835c504b","article-title":"Oral vasodilator therapy in patients with moderate to severe portopulmonary hypertension as a bridge to liver transplantation","volume":"25","author":"Raevens","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2019.06.003_bib86","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/path.1711430106","article-title":"Histometrical investigation of the pulmonary artery in severe hepatic disease","volume":"143","author":"Matsubara","year":"1984","journal-title":"J\u00a0Pathol"},{"issue":"1","key":"10.1016\/j.cld.2019.06.003_bib87","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1183\/09031936.00117511","article-title":"Efficacy, safety, and pharmacokinetics of bosentan in portopulmonary hypertension","volume":"41","author":"Savale","year":"2013","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.cld.2019.06.003_bib88","first-page":"42","article-title":"Effectiveness of phosphodiesterase-5 inhibitor therapy for portopulmonary hypertension","volume":"22","author":"Fisher","year":"2015","journal-title":"Can Respir J"},{"issue":"4","key":"10.1016\/j.cld.2019.06.003_bib89","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1209657","article-title":"Riociguat for the treatment of chronic thromboembolic pulmonary hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.cld.2019.06.003_bib90","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1183\/09031936.00039808","article-title":"First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension","volume":"33","author":"Grimminger","year":"2009","journal-title":"Eur Respir J"},{"issue":"20","key":"10.1016\/j.cld.2019.06.003_bib91","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/CIRCULATIONAHA.110.981738","article-title":"Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease","volume":"123","author":"Stasch","year":"2011","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.cld.2019.06.003_bib92","doi-asserted-by":"crossref","DOI":"10.1177\/2045894018769305","article-title":"Riociguat treatment for portopulmonary hypertension: a subgroup analysis from the PATENT-1\/-2 studies","volume":"8","author":"Cartin-Ceba","year":"2018","journal-title":"Pulm Circ"},{"issue":"1","key":"10.1016\/j.cld.2019.06.003_bib93","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.gastro.2005.10.013","article-title":"Deleterious effects of beta-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension","volume":"130","author":"Provencher","year":"2006","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2019.06.003_bib94","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/hep.510230507","article-title":"Pulmonary hypertension after transjugular intrahepatic portosystemic shunt: effects on right ventricular function","volume":"23","author":"Van der Linden","year":"1996","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2019.06.003_bib95","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/lt.21310","article-title":"Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension","volume":"14","author":"Austin","year":"2008","journal-title":"Liver Transpl"},{"issue":"8","key":"10.1016\/j.cld.2019.06.003_bib96","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/lt.22107","article-title":"Successful outcomes following living donor liver transplantation for portopulmonary hypertension","volume":"16","author":"Bandara","year":"2010","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.cld.2019.06.003_bib97","doi-asserted-by":"crossref","first-page":"543","DOI":"10.4065\/71.6.543","article-title":"Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients","volume":"71","author":"Castro","year":"1996","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.cld.2019.06.003_bib98","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00534-009-0255-7","article-title":"Poor outcome following aborted orthotopic liver transplantation due to severe porto-pulmonary hypertension","volume":"17","author":"Fukazawa","year":"2010","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"issue":"9","key":"10.1016\/j.cld.2019.06.003_bib99","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/lt.20459","article-title":"Hemodynamics and survival of patients with portopulmonary hypertension","volume":"11","author":"Kawut","year":"2005","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2019.06.003_bib100","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/lt.20016","article-title":"Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database","volume":"10","author":"Krowka","year":"2004","journal-title":"Liver Transpl"},{"issue":"7","key":"10.1016\/j.cld.2019.06.003_bib101","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/01.tp.0000235520.37189.fe","article-title":"Portopulmonary hypertension in the early phase following liver transplantation","volume":"82","author":"Saner","year":"2006","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.cld.2019.06.003_bib102","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/lt.22202","article-title":"Portopulmonary hypertension as an indication for combined heart, lung, and liver or lung and liver transplantation: literature review and case presentation","volume":"17","author":"Scouras","year":"2011","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2019.06.003_bib103","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1053\/jlts.2002.31343","article-title":"Outcome of liver transplantation for patients with pulmonary hypertension","volume":"8","author":"Starkel","year":"2002","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2019.06.003_bib104","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1213\/00000539-199610000-00003","article-title":"Moderate primary pulmonary hypertension in patients undergoing liver transplantation","volume":"83","author":"Taura","year":"1996","journal-title":"Anesth Analg"},{"issue":"12 Suppl 3","key":"10.1016\/j.cld.2019.06.003_bib105","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1002\/lt.20975","article-title":"Model for end-stage liver disease (MELD) exception for portopulmonary hypertension","volume":"12","author":"Krowka","year":"2006","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.cld.2019.06.003_bib106","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1053\/j.gastro.2014.01.005","article-title":"Impact of the hepatopulmonary syndrome MELD exception policy on outcomes of patients after liver transplantation: an analysis of the UNOS database","volume":"146","author":"Goldberg","year":"2014","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.cld.2019.06.003_bib107","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1097\/TP.0000000000001666","article-title":"Predictors of waitlist mortality in portopulmonary hypertension","volume":"101","author":"DuBrock","year":"2017","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.cld.2019.06.003_bib108","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/TP.0000000000001517","article-title":"Frequency and outcomes of patients with increased mean pulmonary artery pressure at the time of liver transplantation","volume":"101","author":"DeMartino","year":"2017","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.cld.2019.06.003_bib109","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0735-1097(10)80121-4","article-title":"Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations","volume":"17","author":"Robalino","year":"1991","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.cld.2019.06.003_bib110","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/j.1600-6143.2008.02384.x","article-title":"Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups","volume":"8","author":"Swanson","year":"2008","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.cld.2019.06.003_bib111","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1164\/rccm.200804-613OC","article-title":"Portopulmonary hypertension: survival and prognostic factors","volume":"178","author":"Le Pavec","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.cld.2019.06.003_bib112","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/lt.23870","article-title":"Long-term follow-up of portopulmonary hypertension patients after liver transplantation","volume":"20","author":"Khaderi","year":"2014","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.cld.2019.06.003_bib113","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jhep.2005.03.002","article-title":"Highlights of the ERS Task Force on pulmonary-hepatic vascular disorders (PHD)","volume":"42","author":"Rodriquez-Roisin","year":"2005","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2019.06.003_bib114","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1378\/chest.105.5.1528","article-title":"Hepatopulmonary syndrome. Current concepts in diagnostic and therapeutic considerations","volume":"105","author":"Krowka","year":"1994","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.cld.2019.06.003_bib115","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1378\/chest.72.3.305","article-title":"Exercise-aggravated hypoxemia and orthodeoxia in cirrhosis","volume":"72","author":"Kennedy","year":"1977","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.cld.2019.06.003_bib116","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1053\/j.gastro.2008.06.038","article-title":"Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates","volume":"135","author":"Fallon","year":"2008","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2019.06.003_bib117","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1053\/gast.1997.v113.pm9247483","article-title":"The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndrome","volume":"113","author":"Fallon","year":"1997","journal-title":"Gastroenterology"},{"issue":"4 Pt 1","key":"10.1016\/j.cld.2019.06.003_bib118","first-page":"G779","article-title":"Common bile duct ligation in the rat: a model of intrapulmonary vasodilatation and hepatopulmonary syndrome","volume":"272","author":"Fallon","year":"1997","journal-title":"Am J Physiol"},{"issue":"6","key":"10.1016\/j.cld.2019.06.003_bib119","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/hep.20244","article-title":"The role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the rat","volume":"39","author":"Ling","year":"2004","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2019.06.003_bib120","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/BF02895997","article-title":"Correlation between pulmonary endothelin receptors and alveolar-arterial oxygen gradient in rats with hepatopulmonary syndrome","volume":"25","author":"Liu","year":"2005","journal-title":"J\u00a0Huazhong Univ Sci Technol Med Sci"},{"issue":"2","key":"10.1016\/j.cld.2019.06.003_bib121","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.gastro.2005.05.050","article-title":"Cholangiocyte endothelin 1 and transforming growth factor beta1 production in rat experimental hepatopulmonary syndrome","volume":"129","author":"Luo","year":"2005","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2019.06.003_bib122","first-page":"G944","article-title":"Endothelin-1 stimulation of endothelial nitric oxide synthase in the pathogenesis of hepatopulmonary syndrome","volume":"277","author":"Zhang","year":"1999","journal-title":"Am J Physiol"},{"issue":"2","key":"10.1016\/j.cld.2019.06.003_bib123","doi-asserted-by":"crossref","first-page":"G294","DOI":"10.1152\/ajpgi.00298.2003","article-title":"ET-1 and TNF-alpha in HPS: analysis in prehepatic portal hypertension and biliary and nonbiliary cirrhosis in rats","volume":"286","author":"Luo","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"10","key":"10.1016\/j.cld.2019.06.003_bib124","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1111\/j.1440-1746.2005.03914.x","article-title":"Cirrhotic rats with bacterial translocation have higher incidence and severity of hepatopulmonary syndrome","volume":"20","author":"Sztrymf","year":"2005","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2019.06.003_bib125","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1164\/rccm.201008-1303OC","article-title":"A\u00a0central role for CD68(+) macrophages in hepatopulmonary syndrome. Reversal by macrophage depletion","volume":"183","author":"Thenappan","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.cld.2019.06.003_bib126","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jhep.2012.05.014","article-title":"The role of CX(3)CL1\/CX(3)CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndrome","volume":"57","author":"Zhang","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2019.06.003_bib127","doi-asserted-by":"crossref","first-page":"L346","DOI":"10.1152\/ajplung.00385.2001","article-title":"Regulation of heme oxygenase-1 by nitric oxide during hepatopulmonary syndrome","volume":"283","author":"Carter","year":"2002","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"5","key":"10.1016\/j.cld.2019.06.003_bib128","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.gastro.2003.07.005","article-title":"Analysis of pulmonary heme oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome","volume":"125","author":"Zhang","year":"2003","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2019.06.003_bib129","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/j.gastro.2008.12.001","article-title":"Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome","volume":"136","author":"Zhang","year":"2009","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2019.06.003_bib130","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/hep.22758","article-title":"Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats","volume":"49","author":"Mejias","year":"2009","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.cld.2019.06.003_bib131","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1042\/CS20120052","article-title":"Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis","volume":"124","author":"Chang","year":"2013","journal-title":"Clin Sci (Lond)"},{"issue":"11","key":"10.1016\/j.cld.2019.06.003_bib132","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1183\/09031936.95.08111883","article-title":"Elevated exhaled nitric oxide in patients with hepatopulmonary syndrome","volume":"8","author":"Cremona","year":"1995","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.cld.2019.06.003_bib133","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cld.2014.01.003","article-title":"Hepatopulmonary syndrome","volume":"18","author":"Koch","year":"2014","journal-title":"Clin Liver Dis"},{"issue":"5","key":"10.1016\/j.cld.2019.06.003_bib134","doi-asserted-by":"crossref","first-page":"375","DOI":"10.7326\/0003-4819-129-5-199809010-00005","article-title":"Exhaled nitric oxide and impaired oxygenation in cirrhotic patients before and after liver transplantation","volume":"129","author":"Rolla","year":"1998","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.cld.2019.06.003_bib135","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/j.gastro.2010.03.044","article-title":"Genetic risk factors for hepatopulmonary syndrome in patients with advanced liver disease","volume":"139","author":"Roberts","year":"2010","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2019.06.003_bib136","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s10620-011-1905-6","article-title":"Elevated levels of endothelin-1 in hepatic venous blood are associated with intrapulmonary vasodilatation in humans","volume":"57","author":"Koch","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.cld.2019.06.003_bib137","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1378\/chest.103.2.500","article-title":"Mechanisms of impaired arterial oxygenation in patients with liver cirrhosis and severe respiratory insufficiency. Effects of indomethacin","volume":"103","author":"Andrivet","year":"1993","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.cld.2019.06.003_bib138","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0954-6111(93)90134-L","article-title":"Haemodynamics and gas exchange in liver cirrhosis: the effect of orally administered almitrine bismesylate","volume":"87","author":"Nakos","year":"1993","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.cld.2019.06.003_bib139","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0272-5231(05)70298-7","article-title":"Mechanisms of gas exchange impairment in patients with liver cirrhosis","volume":"17","author":"Agusti","year":"1996","journal-title":"Clin Chest Med"},{"issue":"1","key":"10.1016\/j.cld.2019.06.003_bib140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-5231(05)70295-1","article-title":"Structural and pathologic changes in the lung vasculature in chronic liver disease","volume":"17","author":"Schraufnagel","year":"1996","journal-title":"Clin Chest Med"},{"issue":"6","key":"10.1016\/j.cld.2019.06.003_bib141","first-page":"621","article-title":"Cirrhosis and hypoxia","volume":"63","author":"Keal","year":"1970","journal-title":"Proc R Soc Med"},{"issue":"5","key":"10.1016\/j.cld.2019.06.003_bib142","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/0002-9343(77)90161-9","article-title":"Hypoxemia of cirrhosis: detection of abnormal small pulmonary vascular channels by a quantitative radionuclide method","volume":"63","author":"Wolfe","year":"1977","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.cld.2019.06.003_bib143","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.cgh.2006.12.003","article-title":"Utility of pulse oximetry screening for hepatopulmonary syndrome","volume":"5","author":"Arguedas","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2019.06.003_bib144","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/lt.20931","article-title":"Cost-effectiveness of screening for hepatopulmonary syndrome in liver transplant candidates","volume":"13","author":"Roberts","year":"2007","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.cld.2019.06.003_bib145","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/hep.30139","article-title":"Pulse oximetry is insensitive for detection of hepatopulmonary syndrome in patients evaluated for liver transplantation","volume":"69","author":"Forde","year":"2019","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2019.06.003_bib146","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0016-5085(98)70481-0","article-title":"Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: a new approach","volume":"114","author":"Abrams","year":"1998","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2019.06.003_bib147","doi-asserted-by":"crossref","first-page":"380","DOI":"10.7326\/0003-4819-135-5-200109040-00017","article-title":"Methylene blue improves the hepatopulmonary syndrome","volume":"135","author":"Groneberg","year":"2001","journal-title":"Ann Intern Med"},{"issue":"16","key":"10.1016\/j.cld.2019.06.003_bib148","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJM199410203311617","article-title":"Methylene blue in the hepatopulmonary syndrome","volume":"331","author":"Rolla","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.cld.2019.06.003_bib149","doi-asserted-by":"crossref","first-page":"701","DOI":"10.7326\/0003-4819-133-9-200011070-00012","article-title":"Methylene blue improves the hepatopulmonary syndrome","volume":"133","author":"Schenk","year":"2000","journal-title":"Ann Intern Med"},{"issue":"9377","key":"10.1016\/j.cld.2019.06.003_bib150","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(03)13807-X","article-title":"Effect on dyspnoea and hypoxaemia of inhaled N(G)-nitro-L-arginine methyl ester in hepatopulmonary syndrome","volume":"362","author":"Brussino","year":"2003","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.cld.2019.06.003_bib151","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/hep.21141","article-title":"Effects of nebulized N(G)-nitro-L-arginine methyl ester in patients with hepatopulmonary syndrome","volume":"43","author":"Gomez","year":"2006","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2019.06.003_bib152","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1378\/chest.104.2.515","article-title":"Hepatopulmonary syndrome. Clinical observations and lack of therapeutic response to somatostatin analogue","volume":"104","author":"Krowka","year":"1993","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.cld.2019.06.003_bib153","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1378\/chest.99.4.1027","article-title":"Effects of indomethacin on hepatogenic pulmonary angiodysplasia","volume":"99","author":"Shijo","year":"1991","journal-title":"Chest"},{"issue":"6 Pt 1","key":"10.1016\/j.cld.2019.06.003_bib154","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1542\/peds.97.6.917","article-title":"Long-term aspirin therapy for hepatopulmonary syndrome","volume":"97","author":"Song","year":"1996","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.cld.2019.06.003_bib155","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0025-6196(12)62438-0","article-title":"Severe hypoxemia associated with liver disease: Mayo Clinic experience and the experimental use of almitrine bismesylate","volume":"62","author":"Krowka","year":"1987","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.cld.2019.06.003_bib156","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1164\/ajrccm\/142.2.306","article-title":"Effects of propranolol on arterial oxygenation and oxygen transport to tissues in patients with cirrhosis","volume":"142","author":"Agusti","year":"1990","journal-title":"Am Rev Respir Dis"},{"issue":"1","key":"10.1016\/j.cld.2019.06.003_bib157","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/17843286.1994.11718360","article-title":"Orthodeoxia and platypnea in liver cirrhosis: effects of propranolol","volume":"49","author":"Lambrecht","year":"1994","journal-title":"Acta Clin Belg"},{"issue":"10","key":"10.1016\/j.cld.2019.06.003_bib158","doi-asserted-by":"crossref","first-page":"E131","DOI":"10.1086\/320149","article-title":"Novel presentation and approach to management of hepatopulmonary syndrome with use of antimicrobial agents","volume":"32","author":"Anel","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.cld.2019.06.003_bib159","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.cgh.2010.08.011","article-title":"Norfloxacin therapy for hepatopulmonary syndrome: a pilot randomized controlled trial","volume":"8","author":"Gupta","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2019.06.003_bib160","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/lt.21482","article-title":"Pilot study of pentoxifylline in hepatopulmonary syndrome","volume":"14","author":"Tanikella","year":"2008","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.cld.2019.06.003_bib161","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00004836-199810000-00010","article-title":"Treatment of hepatopulmonary syndrome with Allium sativum L. (garlic): a pilot trial","volume":"27","author":"Abrams","year":"1998","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2019.06.003_bib162","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1155\/2010\/349076","article-title":"The role of garlic in hepatopulmonary syndrome: a randomized controlled trial","volume":"24","author":"De","year":"2010","journal-title":"Can J Gastroenterol"},{"issue":"8","key":"10.1016\/j.cld.2019.06.003_bib163","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/lt.25438","article-title":"Sorafenib in Hepatopulmonary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial","volume":"25","author":"Kawut","year":"2019","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.cld.2019.06.003_bib164","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1097\/00007890-199205000-00029","article-title":"Reversal of cirrhosis-related pulmonary shunting in two children by orthotopic liver transplantation","volume":"53","author":"Laberge","year":"1992","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.cld.2019.06.003_bib165","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1378\/chest.103.4.1271","article-title":"Resolution of severe intrapulmonary shunting after liver transplantation","volume":"103","author":"Schwarzenberg","year":"1993","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.cld.2019.06.003_bib166","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/hep.1840110111","article-title":"Reduction of intrapulmonary shunt and resolution of digital clubbing associated with primary biliary cirrhosis after liver transplantation","volume":"11","author":"Stoller","year":"1990","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2019.06.003_bib167","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1053\/jhep.2003.50023","article-title":"Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation","volume":"37","author":"Arguedas","year":"2003","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2019.06.003_bib168","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1600-6143.2009.02822.x","article-title":"Improved survival after liver transplantation in patients with hepatopulmonary syndrome","volume":"10","author":"Gupta","year":"2010","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.cld.2019.06.003_bib169","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/hep.26070","article-title":"Hepatopulmonary syndrome: favorable outcomes in the MELD exception era","volume":"57","author":"Iyer","year":"2013","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2019.06.003_bib170","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1164\/rccm.201302-0245LE","article-title":"Survival benefits of liver transplant in severe hepatopulmonary syndrome","volume":"188","author":"Iyer","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.cld.2019.06.003_bib171","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0272-5231(05)70302-6","article-title":"The hepatopulmonary syndrome. Effect of liver transplantation","volume":"17","author":"Lange","year":"1996","journal-title":"Clin Chest Med"},{"issue":"9","key":"10.1016\/j.cld.2019.06.003_bib172","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1097\/01.TP.0000061612.78954.6C","article-title":"Liver transplantation for hepatopulmonary syndrome: a ten-year experience in Paris, France","volume":"75","author":"Taille","year":"2003","journal-title":"Transplantation"},{"issue":"12 Suppl 3","key":"10.1016\/j.cld.2019.06.003_bib173","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1002\/lt.20971","article-title":"Model for end-stage liver disease (MELD) exception for hepatopulmonary syndrome","volume":"12","author":"Fallon","year":"2006","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2019.06.003_bib174","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01096-2018","article-title":"Outcome of liver transplantation for hepatopulmonary syndrome: a Eurotransplant experience","volume":"53","author":"Raevens","year":"2019","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.cld.2019.06.003_bib175","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1097\/MCG.0b013e3181da76fc","article-title":"Coexisting hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation","volume":"44","author":"Pham","year":"2010","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2019.06.003_bib176","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01880-2018","article-title":"Development of hepatopulmonary syndrome during combination therapy for portopulmonary hypertension","volume":"53","author":"Olsson","year":"2019","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.cld.2019.06.003_bib177","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/hep.510300307","article-title":"Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): a study of 15 patients with moderate to severe portopulmonary hypertension","volume":"30","author":"Krowka","year":"1999","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2019.06.003_bib178","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00408-013-9501-5","article-title":"Early initiation of prostacyclin in portopulmonary hypertension: 10 years of a transplant center's experience","volume":"191","author":"Awdish","year":"2013","journal-title":"Lung"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108932611930042X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108932611930042X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:56:18Z","timestamp":1761069378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108932611930042X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":178,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S108932611930042X"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2019.06.003","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary Complications of Portal Hypertension","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2019.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}